SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The crypto token $CAW.X, also known as crow with knife, is trending as the community rallies around its unique branding and growing recognition. Community members are highlighting its multichain functionality across $SOL.X, $CRO.X, and $ETH.X, and some users are excited about potential listings on major exchanges like Coinbase.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending following news of a large AI server contract, sparking excitement among investors. Community members are actively discussing potential short squeezes due to the stock's low float and high cost to borrow, while others debate the company's long-term potential within the growing IoT sector.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending due to increased interest in nuclear energy and its potential to power AI data centers, despite the company having no current revenue. The community is debating the stock's high valuation relative to its stage of development, with some anticipating a pullback or secondary offering, while others remain bullish due to the sector's momentum and potential government support. Discussions also highlight comparisons to other energy companies and the potential for a short squeeze.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as community members celebrate its joke-inspired origins and its listing on Jupiter. Many are loading up on the $SOL-based meme coin, while also playfully asking, "What's Updog?" The community is also highlighting the project's donations to animal shelters.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial is trending as investors await the overdue 10-K filing, with many believing its release will trigger a short squeeze. The community is actively discussing potential catalysts, including interest rate decisions and positive business momentum, while expressing frustration over the delays and concerns about the company's compliance. Despite recent losses and auditor changes, some see a turnaround and significant upside potential once the filings are resolved.

Terner is an AI-powered platform on Solana that enables users to create, deploy, and crowdfund innovative projects through natural language interaction. The platform combines advanced AI capabilities with blockchain technology to democratize project creation, offering tools for building web applications, bots, and various digital solutions while providing automated deployment and investment opportunities for creators and investors alike.

Terner

Terner ($TERNER.X) is trending as the community discusses its potential within the Solana ecosystem, highlighting its AI-powered project creation capabilities. Investors are actively accumulating, citing strong buying pressure and anticipating significant gains. Community members are closely monitoring on-chain stats using Phantom.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending with mixed sentiment as the community debates potential price movements and labels those holding the bag as 'suckers.' Some traders are pointing to potential bullish formations and anticipate a rise towards $1, while others believe it is poised to revisit previous lows. Recent news highlights the launch of Sugar Match on Tezos' Etherlink and xU3O8 bringing tokenized Uranium to Tezos.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to speculation surrounding imminent FDA feedback on its HOPE-3 trial, with the community closely watching for news that could significantly impact the company's path forward in treating Duchenne Muscular Dystrophy. The community is weighing the potential outcomes, ranging from accelerated approval to the need for additional studies, while also discussing the implications of recent leadership changes at the FDA. High short interest and the potential for a short squeeze are adding to the heightened interest in CAPR.

CEA Industries, Inc. engages in in the development, design, and distribution of cultivation technologies for controlled environment agriculture, primarily for cannabis crops. It offers controlled climate systems, controls, and biosecurity cultivation products, and MEP engineering, odor control, and installation support services. The company was founded by Brandy Marie Keen and Stephen Keen on October 15, 2009 and is headquartered in Louisville, CO.

CEA Industries Inc

CEA Industries ($BNC) is trending due to a volatile trading day marked by high volume and a significant price drop, sparking discussions around potential ATM offerings and naked short selling. The community is debating the impact of pre-funded warrants and the company's BNB treasury strategy, particularly as BNB hits all-time highs while BNC declines. Some investors believe the stock is undervalued compared to its liquid assets and PIPE investors' entry point, while others express concern about market manipulation and limited buying options.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending as community members weigh its valuation against peers like $OKLO and discuss potential catalysts, including upcoming earnings and developments in the nuclear sector. Some believe $SMR is undervalued compared to other nuclear plays, citing its revenue and regulatory progress. Discussions also involve the broader context of nuclear energy's role in meeting growing power demands, particularly from AI and data centers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VNDA I swear to God if I see one more late night Vanda commercial I may make VNDA my first short ever on principal.  Your company is not doing well enough to waste money.  @Proposition_Joe &amp; @Biotech_Beast know that millions of dollars spent on DTC are better spent getting clinical trials developed, enrolled, and approved. ⏰ 

If I were a Vanda shareholder I would be blasting them constantly for wasting shareholder funds on that crap instead of getting critical clinical trials advanced 😡 

$TNXP $IMRX $CYTK $BHVN aren’t wasting dollars on that bullshit.

Does your leadership think clinical development is cheap or easy?  It isn’t 🏦

Judith

McKenzie

orian

Proposition Joe

Equity investor

Dan Man

Stayinvest

StockTwits for iOS

Vanda Pharmaceuticals Inc

Tonix Pharmaceuticals Holding Corp

Immuneering Corp - Ordinary Shares Class A

Cytokinetics Inc

Biohaven Pharmaceutical Holding Company Ltd

 I swear to God if I see one more late night Vanda commercial I may make VNDA my first short ever on principal.  Your company is not doing well enough to waste money.  

 know that millions of dollars spent on DTC are better spent getting clinical trials developed, enrolled, and approved. ⏰ 

If I were a Vanda shareholder I would be blasting them constantly for wasting shareholder funds on that crap instead of getting critical clinical trials advanced 😡 



 aren’t wasting dollars on that bullshit.

Does your leadership think clinical development is cheap or easy?  It isn’t 🏦